Remdesivir ubat untuk Covid-19
Blog AZA WHO memilih Malaysia untuk menjalankan kajian menguji keberkesanan ubat merawat pesakit Covid-19. Ubat tersebut dikenali sebagai Remdesivir. Ianya belum mendapat kelulusan untuk dijadikan ubat Covid-19. Penyelidikan akan dijalankan di Hospital Sungai Buloh dan sedang dalam proses penyelidikan di beberapa makmal berikut: Severe 2019-nCoV Remdesivir RCT China-Japan Friendship Hospital - Beijing, China Mild/Moderate 2019-nCoV Remdesivir RCT Jin Yin-tan Hospital - Wuhan, China Adaptive COVID-19 Treatment Trial University of Nebraska Medical Center - Omaha NE, USA Expanded Access Remdesivir (RDV; GS-5734™) U.S. Army Medical Research and Development Command Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) Gilead Sciences, Inc. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to St...